New hope for Hard-to-Treat cancers: experimental drug enters human trials
Disease control
Recruiting now
This study tests an experimental drug called GV20-0251 in adults with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug can shrink or control the cancer. About 350 participants with various cancer types will take part in thi…
Phase: PHASE1, PHASE2 • Sponsor: GV20 Therapeutics • Aim: Disease control
Last updated Apr 29, 2026 00:36 UTC